News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Genzyme Corporation (GENZ) in Talks to Sell Itself to Takeda Pharmaceutical Co. Ltd. (TKDG.DE) for $18.5 Billion


11/15/2010 7:40:21 AM

TOKYO (Dow Jones)--Japan's Takeda Pharmaceutical Co. (4502.TO) has explored whether it wanted to pursue a possible acquisition of U.S. biotechnology company Genzyme Corp. (GENZ), but is unlikely to do so, according to people familiar with the matter.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES